| Category | Name | IntersectionWithQuery | PValue | GenesInTerm | GenesInQuery | GenesInTermInQuery | ID |
|---|---|---|---|---|---|---|---|
| GeneOntologyMolecularFunction | zinc ion binding | 1.64e-04 | 891 | 56 | 10 | GO:0008270 | |
| GeneOntologyMolecularFunction | frizzled binding | 2.22e-04 | 42 | 56 | 3 | GO:0005109 | |
| GeneOntologyMolecularFunction | transition metal ion binding | UBR5 RC3H1 CIAPIN1 NFX1 NFXL1 KMT2A ZNFX1 ZMYM3 ZCCHC3 WDFY1 POLR3A | 3.98e-04 | 1189 | 56 | 11 | GO:0046914 |
| GeneOntologyMolecularFunction | diacylglycerol binding | 9.04e-04 | 16 | 56 | 2 | GO:0019992 | |
| GeneOntologyMolecularFunction | low-density lipoprotein particle receptor activity | 9.04e-04 | 16 | 56 | 2 | GO:0005041 | |
| GeneOntologyBiologicalProcess | Wnt signaling pathway involved in forebrain neuroblast division | 6.98e-06 | 2 | 55 | 2 | GO:0021874 | |
| GeneOntologyBiologicalProcess | mammary gland development | 7.12e-05 | 162 | 55 | 5 | GO:0030879 | |
| GeneOntologyBiologicalProcess | axis elongation involved in somitogenesis | 1.04e-04 | 6 | 55 | 2 | GO:0090245 | |
| GeneOntologyBiologicalProcess | response to virus | 1.30e-04 | 425 | 55 | 7 | GO:0009615 | |
| GeneOntologyBiologicalProcess | forebrain neuroblast division | 1.45e-04 | 7 | 55 | 2 | GO:0021873 | |
| GeneOntologyBiologicalProcess | roof of mouth development | 1.71e-04 | 104 | 55 | 4 | GO:0060021 | |
| GeneOntologyCellularComponent | Wnt-Frizzled-LRP5/6 complex | 6.52e-05 | 5 | 54 | 2 | GO:1990851 | |
| Domain | ZnF_NFX | 2.42e-08 | 3 | 55 | 3 | SM00438 | |
| Domain | zf-NF-X1 | 2.42e-08 | 3 | 55 | 3 | PF01422 | |
| Domain | Znf_NFX1 | 2.42e-08 | 3 | 55 | 3 | IPR000967 | |
| Domain | EGF | 4.08e-07 | 235 | 55 | 8 | SM00181 | |
| Domain | EGF-like_dom | 6.32e-07 | 249 | 55 | 8 | IPR000742 | |
| Domain | EGF_1 | 7.57e-07 | 255 | 55 | 8 | PS00022 | |
| Domain | EGF-like_CS | 9.02e-07 | 261 | 55 | 8 | IPR013032 | |
| Domain | EGF_2 | 1.01e-06 | 265 | 55 | 8 | PS01186 | |
| Domain | EGF_3 | 5.54e-06 | 235 | 55 | 7 | PS50026 | |
| Domain | Ldl_recept_b | 8.60e-06 | 14 | 55 | 3 | PF00058 | |
| Domain | LDLRB | 8.60e-06 | 14 | 55 | 3 | PS51120 | |
| Domain | KRAB | 9.35e-06 | 358 | 55 | 8 | PS50805 | |
| Domain | KRAB | 9.35e-06 | 358 | 55 | 8 | PF01352 | |
| Domain | LY | 1.07e-05 | 15 | 55 | 3 | SM00135 | |
| Domain | LDLR_classB_rpt | 1.07e-05 | 15 | 55 | 3 | IPR000033 | |
| Domain | KRAB | 1.16e-05 | 369 | 55 | 8 | SM00349 | |
| Domain | KRAB | 1.19e-05 | 370 | 55 | 8 | IPR001909 | |
| Domain | Znf_C2H2 | ZNF137P ZNF43 ZNF175 ZNF735 ZNF667 ADAMTS17 ZNF814 ZNF397 ZNF786 ZNF222 ZNF445 | 1.88e-05 | 805 | 55 | 11 | IPR007087 |
| Domain | C1_1 | 2.37e-05 | 57 | 55 | 4 | PF00130 | |
| Domain | zf-C2H2 | ZNF137P ZNF43 ZNF175 ZNF735 ZNF667 ZNF814 ZNF397 ZNF786 ZNF222 ZNF445 | 2.99e-05 | 693 | 55 | 10 | PF00096 |
| Domain | ZF_DAG_PE_1 | 3.75e-05 | 64 | 55 | 4 | PS00479 | |
| Domain | ZF_DAG_PE_2 | 3.75e-05 | 64 | 55 | 4 | PS50081 | |
| Domain | C1 | 3.99e-05 | 65 | 55 | 4 | SM00109 | |
| Domain | PE/DAG-bd | 4.24e-05 | 66 | 55 | 4 | IPR002219 | |
| Domain | ACR | 6.72e-05 | 27 | 55 | 3 | SM00608 | |
| Domain | ADAM_Cys-rich | 6.72e-05 | 27 | 55 | 3 | IPR006586 | |
| Domain | ZINC_FINGER_C2H2_2 | ZNF137P ZNF43 ZNF175 ZNF735 ZNF667 ZNF814 ZNF397 ZNF786 ZNF222 ZNF445 | 7.67e-05 | 775 | 55 | 10 | PS50157 |
| Domain | ZINC_FINGER_C2H2_1 | ZNF137P ZNF43 ZNF175 ZNF735 ZNF667 ZNF814 ZNF397 ZNF786 ZNF222 ZNF445 | 7.84e-05 | 777 | 55 | 10 | PS00028 |
| Domain | FYVE | 8.36e-05 | 29 | 55 | 3 | PF01363 | |
| Domain | FYVE | 8.36e-05 | 29 | 55 | 3 | SM00064 | |
| Domain | Growth_fac_rcpt_ | 9.47e-05 | 156 | 55 | 5 | IPR009030 | |
| Domain | ZnF_C2H2 | ZNF137P ZNF43 ZNF175 ZNF735 ZNF667 ZNF814 ZNF397 ZNF786 ZNF222 ZNF445 | 1.08e-04 | 808 | 55 | 10 | SM00355 |
| Domain | Znf_FYVE-rel | 1.36e-04 | 34 | 55 | 3 | IPR017455 | |
| Domain | - | ZNF43 ZNF175 ZNF735 ZNF667 ZNF814 ZNF397 ZNF786 ZNF222 ZNF445 | 1.50e-04 | 679 | 55 | 9 | 3.30.160.60 |
| Domain | Znf_C2H2/integrase_DNA-bd | ZNF43 ZNF175 ZNF735 ZNF667 ZNF814 ZNF397 ZNF786 ZNF222 ZNF445 | 1.76e-04 | 694 | 55 | 9 | IPR013087 |
| Domain | Znf_FYVE | 1.89e-04 | 38 | 55 | 3 | IPR000306 | |
| Domain | EGF_Ca-bd_CS | 1.90e-04 | 97 | 55 | 4 | IPR018097 | |
| Domain | Peptidase_M12B_N | 2.05e-04 | 39 | 55 | 3 | IPR002870 | |
| Domain | Pep_M12B_propep | 2.05e-04 | 39 | 55 | 3 | PF01562 | |
| Domain | - | 2.05e-04 | 39 | 55 | 3 | 2.120.10.30 | |
| Domain | EGF_CA | 2.06e-04 | 99 | 55 | 4 | PS01187 | |
| Domain | ASX_HYDROXYL | 2.14e-04 | 100 | 55 | 4 | PS00010 | |
| Domain | DISINTEGRIN_1 | 2.21e-04 | 40 | 55 | 3 | PS00427 | |
| Domain | Reprolysin | 2.21e-04 | 40 | 55 | 3 | PF01421 | |
| Domain | ZF_FYVE | 2.21e-04 | 40 | 55 | 3 | PS50178 | |
| Domain | ADAM_MEPRO | 2.21e-04 | 40 | 55 | 3 | PS50215 | |
| Domain | DISINTEGRIN_2 | 2.21e-04 | 40 | 55 | 3 | PS50214 | |
| Domain | Peptidase_M12B | 2.21e-04 | 40 | 55 | 3 | IPR001590 | |
| Domain | Disintegrin_dom | 2.38e-04 | 41 | 55 | 3 | IPR001762 | |
| Domain | EGF-type_Asp/Asn_hydroxyl_site | 2.68e-04 | 106 | 55 | 4 | IPR000152 | |
| Domain | 6-blade_b-propeller_TolB-like | 3.35e-04 | 46 | 55 | 3 | IPR011042 | |
| Domain | EGF_CA | 4.57e-04 | 122 | 55 | 4 | SM00179 | |
| Domain | Znf_C2H2-like | ZNF43 ZNF175 ZNF735 ZNF667 ZNF814 ZNF397 ZNF786 ZNF222 ZNF445 | 4.84e-04 | 796 | 55 | 9 | IPR015880 |
| Domain | EGF-like_Ca-bd_dom | 4.86e-04 | 124 | 55 | 4 | IPR001881 | |
| Domain | EGF | 5.16e-04 | 126 | 55 | 4 | PF00008 | |
| Domain | EGF_extracell | 7.34e-04 | 60 | 55 | 3 | IPR013111 | |
| Domain | EGF_2 | 7.34e-04 | 60 | 55 | 3 | PF07974 | |
| Domain | Znf_FYVE_PHD | 9.20e-04 | 147 | 55 | 4 | IPR011011 | |
| Domain | Disintegrin_CS | 9.95e-04 | 16 | 55 | 2 | IPR018358 | |
| Domain | ADAM_CR | 1.26e-03 | 18 | 55 | 2 | PF08516 | |
| Domain | Wnt | 1.41e-03 | 19 | 55 | 2 | IPR005817 | |
| Domain | VWC_out | 1.41e-03 | 19 | 55 | 2 | SM00215 | |
| Domain | Wnt_CS | 1.41e-03 | 19 | 55 | 2 | IPR018161 | |
| Domain | wnt | 1.41e-03 | 19 | 55 | 2 | PF00110 | |
| Domain | WNT1 | 1.41e-03 | 19 | 55 | 2 | SM00097 | |
| Domain | WNT1 | 1.41e-03 | 19 | 55 | 2 | PS00246 | |
| Domain | - | 1.56e-03 | 20 | 55 | 2 | 4.10.70.10 | |
| Domain | Disintegrin | 1.72e-03 | 21 | 55 | 2 | PF00200 | |
| Domain | DISIN | 1.72e-03 | 21 | 55 | 2 | SM00050 | |
| Domain | MetalloPept_cat_dom | 1.75e-03 | 81 | 55 | 3 | IPR024079 | |
| Domain | - | 1.75e-03 | 81 | 55 | 3 | 3.40.390.10 | |
| Domain | EGF_CA | 2.08e-03 | 86 | 55 | 3 | PF07645 | |
| Domain | zf-C2H2_6 | 2.28e-03 | 314 | 55 | 5 | PF13912 | |
| Domain | cEGF | 2.64e-03 | 26 | 55 | 2 | IPR026823 | |
| Domain | cEGF | 2.64e-03 | 26 | 55 | 2 | PF12662 | |
| Domain | ZINC_PROTEASE | 3.02e-03 | 98 | 55 | 3 | PS00142 | |
| Domain | VWC | 3.06e-03 | 28 | 55 | 2 | PF00093 | |
| Domain | VWFC_1 | 5.03e-03 | 36 | 55 | 2 | PS01208 | |
| Domain | VWC | 5.59e-03 | 38 | 55 | 2 | SM00214 | |
| Domain | VWFC_2 | 5.59e-03 | 38 | 55 | 2 | PS50184 | |
| Pathway | WP_WNT_SIGNALING_IN_KIDNEY_DISEASE | 1.64e-04 | 36 | 42 | 3 | M39699 | |
| Pathway | KEGG_MEDICUS_VARIANT_FZD7_OVEREXPRESSION_TO_WNT_SIGNALING_PATHWAY | 1.78e-04 | 37 | 42 | 3 | M47411 | |
| Pathway | REACTOME_SIGNALING_BY_RNF43_MUTANTS | 2.40e-04 | 8 | 42 | 2 | M27433 | |
| Pathway | KEGG_MEDICUS_VARIANT_LRP6_OVEREXPRESSION_TO_WNT_SIGNALING_PATHWAY | 3.20e-04 | 45 | 42 | 3 | M47412 | |
| Pathway | KEGG_MEDICUS_REFERENCE_WNT_SIGNALING_PATHWAY | 3.41e-04 | 46 | 42 | 3 | M47409 | |
| Pathway | WP_ESC_PLURIPOTENCY_PATHWAYS | 3.83e-04 | 116 | 42 | 4 | MM15863 | |
| Pathway | WP_EMBRYONIC_STEM_CELL_PLURIPOTENCY_PATHWAYS | 3.95e-04 | 117 | 42 | 4 | M39530 | |
| Pathway | WP_DEVELOPMENT_OF_URETERIC_COLLECTION_SYSTEM | 7.48e-04 | 60 | 42 | 3 | M40048 | |
| Pathway | REACTOME_NEGATIVE_REGULATION_OF_TCF_DEPENDENT_SIGNALING_BY_WNT_LIGAND_ANTAGONISTS | 8.88e-04 | 15 | 42 | 2 | M27273 | |
| Pathway | BIOCARTA_SPRY_PATHWAY | 1.01e-03 | 16 | 42 | 2 | MM1500 | |
| Pathway | WP_BREAST_CANCER_PATHWAY | 1.11e-03 | 154 | 42 | 4 | M39739 | |
| Pathway | BIOCARTA_SPRY_PATHWAY | 1.15e-03 | 17 | 42 | 2 | M1389 | |
| Pathway | PID_INTEGRIN5_PATHWAY | 1.15e-03 | 17 | 42 | 2 | M212 | |
| Pathway | PID_BETA_CATENIN_DEG_PATHWAY | 1.29e-03 | 18 | 42 | 2 | M31 | |
| Pathway | KEGG_MEDICUS_REFERENCE_WNT_SIGNALING_MODULATION_WNT_ACYLATION | 1.43e-03 | 19 | 42 | 2 | M47836 | |
| Pathway | REACTOME_REGULATION_OF_FZD_BY_UBIQUITINATION | 1.59e-03 | 20 | 42 | 2 | MM15155 | |
| Pathway | PID_WNT_CANONICAL_PATHWAY | 1.59e-03 | 20 | 42 | 2 | M90 | |
| Pathway | REACTOME_REGULATION_OF_FZD_BY_UBIQUITINATION | 1.76e-03 | 21 | 42 | 2 | M27401 | |
| Pubmed | Common variants in the trichohyalin gene are associated with straight hair in Europeans. | 2.32e-07 | 8 | 57 | 3 | 19896111 | |
| Pubmed | Rapid and efficient cloning of cDNAs encoding Krüppel-like zinc finger proteins by degenerate PCR. | 1.30e-06 | 49 | 57 | 4 | 9630514 | |
| Pubmed | 2.64e-06 | 2 | 57 | 2 | 19881541 | ||
| Pubmed | 2.64e-06 | 2 | 57 | 2 | 28331227 | ||
| Pubmed | Wise retained in the endoplasmic reticulum inhibits Wnt signaling by reducing cell surface LRP6. | 2.64e-06 | 2 | 57 | 2 | 17765217 | |
| Pubmed | Clathrin and AP2 are required for PtdIns(4,5)P2-mediated formation of LRP6 signalosomes. | 2.64e-06 | 2 | 57 | 2 | 23400998 | |
| Pubmed | 2.64e-06 | 2 | 57 | 2 | 31726086 | ||
| Pubmed | 2.64e-06 | 2 | 57 | 2 | 17698587 | ||
| Pubmed | 2.64e-06 | 2 | 57 | 2 | 35384384 | ||
| Pubmed | 5.44e-06 | 21 | 57 | 3 | 17943183 | ||
| Pubmed | 7.91e-06 | 3 | 57 | 2 | 25143377 | ||
| Pubmed | 7.91e-06 | 3 | 57 | 2 | 25425204 | ||
| Pubmed | Wnt induces LRP6 signalosomes and promotes dishevelled-dependent LRP6 phosphorylation. | 7.91e-06 | 3 | 57 | 2 | 17569865 | |
| Pubmed | ZDHHC19 localizes to the cell membrane of spermatids and is involved in spermatogenesis†. | 7.91e-06 | 3 | 57 | 2 | 34897408 | |
| Pubmed | 7.91e-06 | 3 | 57 | 2 | 25301448 | ||
| Pubmed | Wnt3a-stimulated LRP6 phosphorylation is dependent upon arginine methylation of G3BP2. | 7.91e-06 | 3 | 57 | 2 | 22357953 | |
| Pubmed | A novel mechanism for Wnt activation of canonical signaling through the LRP6 receptor. | 7.91e-06 | 3 | 57 | 2 | 12897152 | |
| Pubmed | Anti-LRP5/6 VHHs promote differentiation of Wnt-hypersensitive intestinal stem cells. | 7.91e-06 | 3 | 57 | 2 | 30664649 | |
| Pubmed | IGFBP-4 is an inhibitor of canonical Wnt signalling required for cardiogenesis. | 1.58e-05 | 4 | 57 | 2 | 18528331 | |
| Pubmed | ZDHHC11 modulates innate immune response to DNA virus by mediating MITA-IRF3 association. | 1.58e-05 | 4 | 57 | 2 | 29429998 | |
| Pubmed | Wnt5a regulates distinct signalling pathways by binding to Frizzled2. | 1.58e-05 | 4 | 57 | 2 | 19910923 | |
| Pubmed | Wnt co-receptors Lrp5 and Lrp6 differentially mediate Wnt3a signaling in osteoblasts. | 1.58e-05 | 4 | 57 | 2 | 29176883 | |
| Pubmed | 1.58e-05 | 4 | 57 | 2 | 20301293 | ||
| Pubmed | Tiki1 is required for head formation via Wnt cleavage-oxidation and inactivation. | 1.58e-05 | 4 | 57 | 2 | 22726442 | |
| Pubmed | 1.58e-05 | 4 | 57 | 2 | 14739301 | ||
| Pubmed | ESCPE-1 mediates retrograde endosomal sorting of the SARS-CoV-2 host factor Neuropilin-1. | 2.29e-05 | 1201 | 57 | 10 | 35696571 | |
| Pubmed | 2.63e-05 | 5 | 57 | 2 | 12590922 | ||
| Pubmed | TRAF6 function as a novel co-regulator of Wnt3a target genes in prostate cancer. | 2.63e-05 | 5 | 57 | 2 | 31262711 | |
| Pubmed | structural Studies of Wnts and identification of an LRP6 binding site. | 2.63e-05 | 5 | 57 | 2 | 23791946 | |
| Pubmed | 2.63e-05 | 5 | 57 | 2 | 24265322 | ||
| Pubmed | 2.63e-05 | 5 | 57 | 2 | 20137080 | ||
| Pubmed | Wnt antagonists bind through a short peptide to the first β-propeller domain of LRP5/6. | 2.63e-05 | 5 | 57 | 2 | 21944579 | |
| Pubmed | 2.63e-05 | 5 | 57 | 2 | 12121999 | ||
| Pubmed | 3.12e-05 | 37 | 57 | 3 | 15342465 | ||
| Pubmed | Tissue-specific requirements of beta-catenin in external genitalia development. | 3.38e-05 | 38 | 57 | 3 | 18635608 | |
| Pubmed | 3.94e-05 | 6 | 57 | 2 | 19075000 | ||
| Pubmed | Requirement of prorenin receptor and vacuolar H+-ATPase-mediated acidification for Wnt signaling. | 3.94e-05 | 6 | 57 | 2 | 20093472 | |
| Pubmed | 3.94e-05 | 6 | 57 | 2 | 17888405 | ||
| Pubmed | ZDHHC11 Positively Regulates NF-κB Activation by Enhancing TRAF6 Oligomerization. | 3.94e-05 | 6 | 57 | 2 | 34490261 | |
| Pubmed | 5.43e-05 | 407 | 57 | 6 | 12693553 | ||
| Pubmed | 5.51e-05 | 7 | 57 | 2 | 23687301 | ||
| Pubmed | 6.43e-05 | 47 | 57 | 3 | 18351675 | ||
| Pubmed | Wnt antagonist SFRP3 inhibits the differentiation of mouse hepatic progenitor cells. | 7.29e-05 | 49 | 57 | 3 | 19562671 | |
| Pubmed | Adamts17 is involved in skeletogenesis through modulation of BMP-Smad1/5/8 pathway. | 7.34e-05 | 8 | 57 | 2 | 31201465 | |
| Pubmed | 7.34e-05 | 8 | 57 | 2 | 20093360 | ||
| Pubmed | Identification of genetic risk factors for maxillary lateral incisor agenesis. | 7.34e-05 | 8 | 57 | 2 | 24554542 | |
| Pubmed | 9.43e-05 | 9 | 57 | 2 | 22899650 | ||
| Pubmed | Caveolin is necessary for Wnt-3a-dependent internalization of LRP6 and accumulation of beta-catenin. | 9.43e-05 | 9 | 57 | 2 | 16890161 | |
| Pubmed | Transcriptional profiling reveals ductus arteriosus-specific genes that regulate vascular tone. | 9.43e-05 | 9 | 57 | 2 | 24790087 | |
| Pubmed | 9.43e-05 | 9 | 57 | 2 | 16543246 | ||
| Pubmed | 9.43e-05 | 9 | 57 | 2 | 16339969 | ||
| Pubmed | An LDL-receptor-related protein mediates Wnt signalling in mice. | 9.43e-05 | 9 | 57 | 2 | 11029008 | |
| Pubmed | 1.18e-04 | 10 | 57 | 2 | 15143170 | ||
| Pubmed | 1.18e-04 | 10 | 57 | 2 | 32822074 | ||
| Pubmed | 1.44e-04 | 11 | 57 | 2 | 18606138 | ||
| Pubmed | ZNRF3 promotes Wnt receptor turnover in an R-spondin-sensitive manner. | 1.44e-04 | 11 | 57 | 2 | 22575959 | |
| Pubmed | 1.44e-04 | 11 | 57 | 2 | 24639464 | ||
| Pubmed | 1.66e-04 | 167 | 57 | 4 | 22159717 | ||
| Pubmed | Molecular dynamics of Dkk4 modulates Wnt action and regulates meibomian gland development. | 1.72e-04 | 12 | 57 | 2 | 27864382 | |
| Pubmed | 1.72e-04 | 12 | 57 | 2 | 26813283 | ||
| Pubmed | The importance of Wnt signalling for neurodegeneration in Parkinson's disease. | 1.72e-04 | 12 | 57 | 2 | 22988876 | |
| Pubmed | Separate and distinctive roles for Wnt5a in tongue, lingual tissue and taste papilla development. | 2.03e-04 | 13 | 57 | 2 | 22024319 | |
| Pubmed | 2.20e-04 | 71 | 57 | 3 | 33541421 | ||
| Pubmed | A mechanism for gene-environment interaction in the etiology of congenital scoliosis. | 2.37e-04 | 14 | 57 | 2 | 22484060 | |
| Pubmed | 2.73e-04 | 15 | 57 | 2 | 11429295 | ||
| Pubmed | 2.73e-04 | 15 | 57 | 2 | 15044261 | ||
| Pubmed | 3.12e-04 | 16 | 57 | 2 | 10585256 | ||
| Pubmed | 3.12e-04 | 16 | 57 | 2 | 9889131 | ||
| Pubmed | Mapping of Wnt-Frizzled interactions by multiplex CRISPR targeting of receptor gene families. | 3.53e-04 | 17 | 57 | 2 | 28733458 | |
| Pubmed | Gata3 is required for early morphogenesis and Fgf10 expression during otic development. | 3.97e-04 | 18 | 57 | 2 | 16806848 | |
| Pubmed | Proteolysis of fibrillin-2 microfibrils is essential for normal skeletal development. | 3.97e-04 | 18 | 57 | 2 | 35503090 | |
| Pubmed | 3.97e-04 | 18 | 57 | 2 | 10842103 | ||
| Pubmed | 4.43e-04 | 90 | 57 | 3 | 19515997 | ||
| Pubmed | Coronary Artery Formation Is Driven by Localized Expression of R-spondin3. | 4.43e-04 | 19 | 57 | 2 | 28834739 | |
| Pubmed | 4.43e-04 | 19 | 57 | 2 | 18258849 | ||
| Pubmed | 4.43e-04 | 19 | 57 | 2 | 12878679 | ||
| Pubmed | 4.43e-04 | 19 | 57 | 2 | 11520664 | ||
| Pubmed | Regulation of angiogenesis by a non-canonical Wnt-Flt1 pathway in myeloid cells. | 4.43e-04 | 19 | 57 | 2 | 21623369 | |
| Pubmed | A Wnt-bmp feedback circuit controls intertissue signaling dynamics in tooth organogenesis. | 4.92e-04 | 20 | 57 | 2 | 22234613 | |
| Pubmed | 5.43e-04 | 21 | 57 | 2 | 19806668 | ||
| Pubmed | MESD is essential for apical localization of megalin/LRP2 in the visceral endoderm. | 5.43e-04 | 21 | 57 | 2 | 21337463 | |
| Pubmed | MT1-MMP inactivates ADAM9 to regulate FGFR2 signaling and calvarial osteogenesis. | 5.43e-04 | 21 | 57 | 2 | 22632802 | |
| Pubmed | The WNT7b promoter is regulated by TTF-1, GATA6, and Foxa2 in lung epithelium. | 5.43e-04 | 21 | 57 | 2 | 11914369 | |
| Pubmed | Epithelial Wnt10a Is Essential for Tooth Root Furcation Morphogenesis. | 5.43e-04 | 21 | 57 | 2 | 31914354 | |
| Pubmed | 5.43e-04 | 21 | 57 | 2 | 27894818 | ||
| Pubmed | Evolutionarily conserved requirement of Cdx for post-occipital tissue emergence. | 5.43e-04 | 21 | 57 | 2 | 22675207 | |
| Pubmed | 5.97e-04 | 22 | 57 | 2 | 12815618 | ||
| Pubmed | 5.97e-04 | 22 | 57 | 2 | 17064353 | ||
| Pubmed | 5.97e-04 | 22 | 57 | 2 | 18991257 | ||
| Pubmed | FGF4 and FGF8 comprise the wavefront activity that controls somitogenesis. | 6.53e-04 | 23 | 57 | 2 | 21368122 | |
| Pubmed | 6.53e-04 | 23 | 57 | 2 | 27362799 | ||
| Pubmed | 6.73e-04 | 650 | 57 | 6 | 38777146 | ||
| Pubmed | 9.02e-04 | 27 | 57 | 2 | 17804636 | ||
| Pubmed | Compartment-dependent activities of Wnt3a/β-catenin signaling during vertebrate axial extension. | 9.02e-04 | 27 | 57 | 2 | 25152336 | |
| Pubmed | Genetic link between renal birth defects and congenital heart disease. | 9.71e-04 | 28 | 57 | 2 | 27002738 | |
| Pubmed | 9.71e-04 | 28 | 57 | 2 | 20940229 | ||
| Pubmed | Ectodermal Wnt signaling regulates abdominal myogenesis during ventral body wall development. | 9.71e-04 | 28 | 57 | 2 | 24394376 | |
| Pubmed | Wnt5a potentiates TGF-β signaling to promote colonic crypt regeneration after tissue injury. | 1.04e-03 | 29 | 57 | 2 | 22956684 | |
| Pubmed | 1.04e-03 | 29 | 57 | 2 | 18364260 | ||
| Pubmed | 1.05e-03 | 709 | 57 | 6 | 22988430 | ||
| Interaction | LYZL1 interactions | 1.74e-05 | 118 | 55 | 5 | int:LYZL1 | |
| Interaction | LYPD1 interactions | 1.89e-05 | 58 | 55 | 4 | int:LYPD1 | |
| Interaction | NTN5 interactions | 3.74e-05 | 24 | 55 | 3 | int:NTN5 | |
| Interaction | GPHA2 interactions | 4.24e-05 | 25 | 55 | 3 | int:GPHA2 | |
| Interaction | GGH interactions | 5.11e-05 | 243 | 55 | 6 | int:GGH | |
| Interaction | IGFL3 interactions | 5.23e-05 | 75 | 55 | 4 | int:IGFL3 | |
| Interaction | NMS interactions | 7.41e-05 | 30 | 55 | 3 | int:NMS | |
| Interaction | SIRPD interactions | 8.93e-05 | 86 | 55 | 4 | int:SIRPD | |
| Interaction | DKK1 interactions | 9.02e-05 | 32 | 55 | 3 | int:DKK1 | |
| GeneFamily | Zinc fingers C2H2-type|ZF class homeoboxes and pseudogenes | ZNF43 ZNF175 ZNF735 ZNF667 ZNF814 ZNF397 ZNF786 ZNF222 ZNF445 | 2.11e-05 | 718 | 40 | 9 | 28 |
| GeneFamily | Zinc fingers FYVE-type|Pleckstrin homology domain containing|Rho guanine nucleotide exchange factors | 4.32e-05 | 31 | 40 | 3 | 81 | |
| GeneFamily | Low density lipoprotein receptors | 3.67e-04 | 13 | 40 | 2 | 634 | |
| GeneFamily | Wnt family|Endogenous ligands | 7.97e-04 | 19 | 40 | 2 | 360 | |
| GeneFamily | Zinc fingers DHHC-type|Ankyrin repeat domain containing | 1.28e-03 | 24 | 40 | 2 | 76 | |
| GeneFamily | ADAM metallopeptidase domain containing|CD molecules | 1.62e-03 | 27 | 40 | 2 | 47 | |
| GeneFamily | PHD finger proteins | 1.69e-02 | 90 | 40 | 2 | 88 | |
| Coexpression | NABA_MATRISOME | SLIT2 FRAS1 FBN1 EGF CRIM1 ADAM21 ADAM9 WNT3A ADAMTS17 WNT10A COLQ | 6.53e-06 | 1008 | 55 | 11 | MM17056 |
| Coexpression | NABA_MATRISOME | SLIT2 FRAS1 FBN1 EGF CRIM1 ADAM21 ADAM9 WNT3A ADAMTS17 WNT10A COLQ | 7.72e-06 | 1026 | 55 | 11 | M5889 |
| Coexpression | WANG_RESPONSE_TO_BEXAROTENE_UP | 5.00e-05 | 34 | 55 | 3 | M1263 | |
| Coexpression | NABA_ECM_GLYCOPROTEINS | 5.05e-05 | 191 | 55 | 5 | MM17059 | |
| Coexpression | NABA_ECM_GLYCOPROTEINS | 5.71e-05 | 196 | 55 | 5 | M3008 | |
| Coexpression | LAKE_ADULT_KIDNEY_C14_DISTAL_CONVOLUTED_TUBULE | 7.56e-05 | 208 | 55 | 5 | M39233 | |
| ToppCell | renal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Epithelial-Distal_tubule_epithelial_cell-kidney_distal_convoluted_tubule_epithelial_cell-Distal_Convoluted_Tubule_Cell_Type_1|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 1.54e-07 | 189 | 57 | 6 | 975c0f079903ae36b0ffa54e86294d42ec7697de | |
| ToppCell | renal_medulla_nuclei-Hypertensive_with+without-CKD-Epithelial-Distal_tubule_epithelial_cell-kidney_distal_convoluted_tubule_epithelial_cell-Distal_Convoluted_Tubule_Cell_Type_1|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 2.83e-06 | 173 | 57 | 5 | 4bc6d93716f093b460c8b047199db8cab5fea720 | |
| ToppCell | renal_medulla_nuclei-Hypertensive_with+without-CKD-Epithelial-Distal_tubule_epithelial_cell-kidney_distal_convoluted_tubule_epithelial_cell|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 3.52e-06 | 181 | 57 | 5 | e0abf2707d9e0aa942c657eef7d2cbcd02f060dd | |
| ToppCell | human_hepatoblastoma-Tumor_cells-T5|Tumor_cells / Sample and Cell Type and Tumor Cluster (all cells) | 4.24e-06 | 188 | 57 | 5 | b070a0667f1ee9b825b267b6c389b7c42fc436f9 | |
| ToppCell | renal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Epithelial-Distal_tubule_epithelial_cell-kidney_distal_convoluted_tubule_epithelial_cell|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 4.35e-06 | 189 | 57 | 5 | 7eb8f5a951e80f1cfac4d7c9eb169f4eb100c917 | |
| ToppCell | PCW_05-06-Mesenchymal-Mesenchymal_fibroblastic-mes_adventitial_fibro_(10)|PCW_05-06 / Celltypes from embryonic and fetal-stage human lung | 4.58e-06 | 191 | 57 | 5 | 156b467187331ac6ca390d6ca861d9670bb7b956 | |
| ToppCell | LPS_IL1RA-Mesenchymal_fibroblastic-Fibroblasts-Activated_MatrixFB|LPS_IL1RA / Treatment groups by lineage, cell group, cell type | 5.59e-06 | 199 | 57 | 5 | 8b86c69aaf60feff53aa782559cfece7342a23de | |
| ToppCell | Control_saline-Mesenchymal_myocytic-Pericyte-Pericyte_2|Control_saline / Treatment groups by lineage, cell group, cell type | 5.73e-06 | 200 | 57 | 5 | bc8949eb34482aca166c4602ff6ab876cb4c2c3c | |
| ToppCell | renal_medulla_nuclei-CKD+DKD_normotensive-Epithelial-Distal_tubule_epithelial_cell-kidney_distal_convoluted_tubule_epithelial_cell|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group | 3.12e-05 | 140 | 57 | 4 | 5e81fa3a19d23f0e9cae3878431ca1f78dff7238 | |
| ToppCell | renal_medulla_nuclei-Renal_AKI_(acute_kidney_injury)-Epithelial-Distal_tubule_epithelial_cell-kidney_distal_convoluted_tubule_epithelial_cell|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 3.30e-05 | 142 | 57 | 4 | 5b6b0c611c83b23ef7289854a515b78f6cf84500 | |
| ToppCell | renal_cortex_nuclei-CKD+DKD_normotensive-Epithelial-Distal_tubule_epithelial_cell-kidney_loop_of_Henle_thick_ascending_limb_epithelial_cell-Cortical_Thick_Ascending_Limb_Cell|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group | 5.38e-05 | 161 | 57 | 4 | 4bb7bae54ba3bdf46b525c01f5ad3db8e49819cb | |
| ToppCell | E16.5-samps-Mesenchymal-Matrix_fibroblast-_fetal-Mature_Fibroblast_1|E16.5-samps / Age Group, Lineage, Cell class and subclass | 5.65e-05 | 163 | 57 | 4 | f1ec2625b52664308968b01d8e0275e1e0751480 | |
| ToppCell | wk_15-18-Mesenchymal-Fibroblast-Mesenchymal_3|wk_15-18 / Celltypes from embryonic and fetal-stage human lung | 7.11e-05 | 173 | 57 | 4 | b43817a6b1ed8d6b5366702343be4311c0d52d83 | |
| ToppCell | PND10-Mesenchymal-Mesenchymal_myocytic-Myofibroblast_vascular-Pericyte-Pericyte_G2M|PND10 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 7.44e-05 | 175 | 57 | 4 | 15c69dd5635c9251c535f1e22467712e9667ae92 | |
| ToppCell | facs-Lung-nan-3m-Mesenchymal-Alveolar_Fibroblast|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 8.66e-05 | 182 | 57 | 4 | dbe4b2557cf19e0682ed446f8397d3a1153642f0 | |
| ToppCell | facs-Lung-nan-3m-Mesenchymal-fibroblast_of_lung|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 8.66e-05 | 182 | 57 | 4 | c557de6ccd327c46e0a5423cd9936d78e0abae5f | |
| ToppCell | renal_medulla_nuclei-CKD+DKD_normotensive-Epithelial-Distal_tubule_epithelial_cell-kidney_loop_of_Henle_thick_ascending_limb_epithelial_cell-Medullary_Thick_Ascending_Limb_Cell|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group | 8.66e-05 | 182 | 57 | 4 | 041bc819e6cf2618bf86bce8dfe2df673f392ba3 | |
| ToppCell | COVID-19-Heart-CM_4|COVID-19 / Disease (COVID-19 only), tissue and cell type | 8.84e-05 | 183 | 57 | 4 | 2902b6e8aa9a6f62bc1a792c971ab7f651a8e676 | |
| ToppCell | renal_medulla_nuclei-CKD+DKD_normotensive-Epithelial-Distal_tubule_epithelial_cell-kidney_loop_of_Henle_thick_ascending_limb_epithelial_cell|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group | 8.84e-05 | 183 | 57 | 4 | 31ab55d5f3639f5964541d5eae23044dbda3356e | |
| ToppCell | LPS-IL1RA+antiTNF-Stromal_mesenchymal-Lung_smooth_muscle-Pericyte_2|LPS-IL1RA+antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 8.84e-05 | 183 | 57 | 4 | 8a799807fbf24456a9811e0c64068187940a2f71 | |
| ToppCell | renal_cortex_nuclei-Hypertensive_with+without-CKD-Epithelial-Distal_tubule_epithelial_cell-kidney_distal_convoluted_tubule_epithelial_cell-Distal_Convoluted_Tubule_Cell_Type_2|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 8.84e-05 | 183 | 57 | 4 | 2e831a4d99c6f983793df71c0994124c943c6da9 | |
| ToppCell | renal_medulla_nuclei-CKD+DKD_normotensive-Epithelial-Distal_tubule_epithelial_cell|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group | 9.22e-05 | 185 | 57 | 4 | 898a093757f86be3e18d2ef1f16a71f50ef81dc3 | |
| ToppCell | droplet-Lung-30m-Mesenchymal-fibroblast-adventitial_fibroblast-adventitial_fibroblast_l49|30m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 9.22e-05 | 185 | 57 | 4 | 355b03c7ea438681e11a2b872c798c9ea26e1486 | |
| ToppCell | LPS-antiTNF-Stromal_mesenchymal-Lung_smooth_muscle-Pericyte_3|LPS-antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 9.41e-05 | 186 | 57 | 4 | 4780af76237d7af2abbe2d8d5530cdf53e3ed0b7 | |
| ToppCell | renal_medulla_nuclei-CKD+DKD_normotensive-Epithelial-Distal_tubule_epithelial_cell-kidney_loop_of_Henle_thick_ascending_limb_epithelial_cell-Cortical_Thick_Ascending_Limb_Cell|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group | 9.61e-05 | 187 | 57 | 4 | b93cf4dfe8ffb89348ee7bccc9f284189f7240a2 | |
| ToppCell | renal_cortex_nuclei-Adult_normal_reference-Epithelial-Distal_tubule_epithelial_cell-kidney_loop_of_Henle_thick_ascending_limb_epithelial_cell-Cortical_Thick_Ascending_Limb_Cell|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 9.61e-05 | 187 | 57 | 4 | 7ea8731288e2a99f45e3958590ee1d76f49ae888 | |
| ToppCell | renal_cortex_nuclei-CKD+DKD_normotensive-Epithelial-Intermediate_tubule_epithelial_cell-kidney_loop_of_Henle_thick_ascending_limb_epithelial_cell-Adaptive_/_Maladaptive_/_Repairing_Thick_Ascending_Limb_Cell|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group | 9.61e-05 | 187 | 57 | 4 | 87b3d0478693d4c54ff06b74e5903036b9c1ee6a | |
| ToppCell | renal_cortex_nuclei-CKD+DKD_normotensive-Epithelial-Intermediate_tubule_epithelial_cell|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group | 9.61e-05 | 187 | 57 | 4 | 42a1267bfc27b4460b8409ada580a87c4385841c | |
| ToppCell | renal_cortex_nuclei-CKD+DKD_normotensive-Epithelial-Intermediate_tubule_epithelial_cell-kidney_loop_of_Henle_thick_ascending_limb_epithelial_cell|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group | 9.61e-05 | 187 | 57 | 4 | 64afdea159f5e67a1e5cea35ce898aae6e80aea5 | |
| ToppCell | Control-Fibroblasts-Alveolar_FB|Control / group, cell type (main and fine annotations) | 9.61e-05 | 187 | 57 | 4 | 92d468dde81125d51daf7abd4703741abe1ab91c | |
| ToppCell | -Unknown-Endothelial-Myofibroblast| / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 9.81e-05 | 188 | 57 | 4 | 6468fa95ad0395395301115286f2d8c0df5d3882 | |
| ToppCell | -Unknown-Endothelial| / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 9.81e-05 | 188 | 57 | 4 | 7a81ac5c79c3eb26639b52d2b9fd5e7ef9798fd6 | |
| ToppCell | -Unknown| / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 9.81e-05 | 188 | 57 | 4 | 9cb718bfe1358c6fd842f096e228eb0abb9aefc6 | |
| ToppCell | renal_cortex_nuclei-Adult_normal_reference-Epithelial-Distal_tubule_epithelial_cell-kidney_loop_of_Henle_thick_ascending_limb_epithelial_cell|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 9.81e-05 | 188 | 57 | 4 | 3cee9916399e2e7580cecbcbb27424a71e7e7ac0 | |
| ToppCell | COVID-19-kidney-DCT|kidney / Disease (COVID-19 only), tissue and cell type | 9.81e-05 | 188 | 57 | 4 | df1fd0819d301679f3c9ea404e942e39095912eb | |
| ToppCell | renal_cortex_nuclei-Adult_normal_reference-Epithelial-Distal_tubule_epithelial_cell|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 1.00e-04 | 189 | 57 | 4 | f51cdc9a47371cab8ed9ae63a6f14da07ede446c | |
| ToppCell | renal_cortex_nuclei-CKD+DKD_normotensive-Epithelial-Distal_tubule_epithelial_cell-kidney_distal_convoluted_tubule_epithelial_cell|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group | 1.00e-04 | 189 | 57 | 4 | e32172ad09e93f6ac6ea2b92145b2b73003f7970 | |
| ToppCell | droplet-Lung-LUNG-1m-Mesenchymal-fibroblast_of_lung|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.00e-04 | 189 | 57 | 4 | 32e6d6285b258831b965281224ff2aaeecdcb5f5 | |
| ToppCell | renal_cortex_nuclei-Adult_normal_reference-Epithelial-Distal_tubule_epithelial_cell-kidney_distal_convoluted_tubule_epithelial_cell-Distal_Convoluted_Tubule_Cell_Type_1|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 1.00e-04 | 189 | 57 | 4 | 977a813e5d7a5a561c1fced2bbf21c20056b88d8 | |
| ToppCell | droplet-Lung-LUNG-1m-Mesenchymal-Alveolar_Fibroblast|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.00e-04 | 189 | 57 | 4 | 385ef7bbd76c8047aeecf6542377d4213b5da5db | |
| ToppCell | Primary_Visual_cortex_(V1C)-Neuronal-Glutamatergic_Excit-Glut_C-D_(RORB)-Glut_C_(IT_L4_RORB)|Primary_Visual_cortex_(V1C) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 1.02e-04 | 190 | 57 | 4 | 1bbbf0ce222e51f9fd2daca0c18d3965fd4efd31 | |
| ToppCell | renal_cortex_nuclei-Hypertensive_with+without-CKD-Epithelial-Distal_tubule_epithelial_cell|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 1.02e-04 | 190 | 57 | 4 | b94df372bc08de11585b2467dba8c8fffff5cd92 | |
| ToppCell | COVID-19-Heart-CM_4|Heart / Disease (COVID-19 only), tissue and cell type | 1.02e-04 | 190 | 57 | 4 | 3729648a17093b438398b82e32bbccc3af7b8c5d | |
| ToppCell | renal_medulla_nuclei-Adult_normal_reference-Epithelial-Distal_tubule_epithelial_cell-kidney_loop_of_Henle_thick_ascending_limb_epithelial_cell-Cortical_Thick_Ascending_Limb_Cell|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 1.02e-04 | 190 | 57 | 4 | cc17ab84a9328124f146951c06be3eff9650d9fd | |
| ToppCell | renal_cortex_nuclei-Adult_normal_reference-Epithelial-Distal_tubule_epithelial_cell-kidney_distal_convoluted_tubule_epithelial_cell|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 1.02e-04 | 190 | 57 | 4 | e252e925600e6457fa6e362a55217f4cffa75cdb | |
| ToppCell | nucseq-Mesenchymal-Fibroblastic-Fibroblastic_2-AF1|nucseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2 | 1.04e-04 | 191 | 57 | 4 | 6688cee34beee4f151ac17fccbc9c26a9aad72e1 | |
| ToppCell | nucseq-Mesenchymal-Fibroblastic-Fibroblastic_2|nucseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2 | 1.06e-04 | 192 | 57 | 4 | 99ce9e3c4c50cf64ebb62145f2b5420efa0db309 | |
| ToppCell | LPS_only-Stromal_mesenchymal-Matrix_Fibroblast-Activated_MatrixFB|LPS_only / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 1.06e-04 | 192 | 57 | 4 | df1545670370fb1010c567cd059c2783eab315f7 | |
| ToppCell | PND28-Mesenchymal-Mesenchymal_structural-Fibroblastic-AF1-AF1_mature|PND28 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 1.09e-04 | 193 | 57 | 4 | 4c74a3f69b2cbdf139e7e66b44bd86869ac34dc0 | |
| ToppCell | facs-Lung-EPCAM-3m-Mesenchymal-fibroblast_of_lung|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.09e-04 | 193 | 57 | 4 | 027e098ad018e782287f84eee0f77551018f2196 | |
| ToppCell | PND28-Mesenchymal-Mesenchymal_structural-Fibroblastic-AF1|PND28 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 1.09e-04 | 193 | 57 | 4 | ff8ceeb3cfd1bef7239df490c19d181091750833 | |
| ToppCell | facs-Lung-EPCAM-3m-Mesenchymal-Alveolar_Fibroblast|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.09e-04 | 193 | 57 | 4 | c5463a87f20b3a7f7ffda677b2f5a0e9e49d6685 | |
| ToppCell | Smart-start-Cell-Wel_seq-Neoplastic-Differentiated-like-MES-like-MES-like_hypoxia_independent-G|Smart-start-Cell-Wel_seq / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 1.11e-04 | 194 | 57 | 4 | f44394c8a6f86483063f2f5722f003a8a0a70254 | |
| ToppCell | renal_medulla_nuclei-CKD+DKD_normotensive-Epithelial|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group | 1.13e-04 | 195 | 57 | 4 | 6477e6e7be5bd8eb99119a12ae16334ccddecd43 | |
| ToppCell | COVID-19-Fibroblasts-Alveolar_FB|COVID-19 / group, cell type (main and fine annotations) | 1.13e-04 | 195 | 57 | 4 | 603050beeb33c331d4b2e3fa46cae3f3e0e4bdc7 | |
| ToppCell | Parenchymal-NucSeq-Immune_Myeloid-Macrophage_alveolar-Macro_alv_dividing|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 1.17e-04 | 197 | 57 | 4 | d669d90c3f9e98b41bcbc49dbdc5698e0b42597c | |
| ToppCell | Tracheal-10x5prime-Stromal-Myofibroblastic-Muscle_smooth_airway_ASM|10x5prime / Cell types per location group and 10X technology with lineage, and cell group designations | 1.20e-04 | 198 | 57 | 4 | 1e1ea54f0c234f3b6d29064c4881d8a0c0949a75 | |
| ToppCell | Bronchial-NucSeq-Immune_Myeloid-Macrophage_other-Macro_CHIT1|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 1.20e-04 | 198 | 57 | 4 | 0b41b3d6c2db795320e8b65d40d85fb8b618cc34 | |
| ToppCell | Control_saline-Mesenchymal_fibroblastic-Fibroblasts-Activated_MatrixFB|Control_saline / Treatment groups by lineage, cell group, cell type | 1.20e-04 | 198 | 57 | 4 | 0c4d2c68a42f8a9e964e2dd28092fe75f5216834 | |
| ToppCell | Tracheal|World / Cell types per location group and 10X technology with lineage, and cell group designations | 1.24e-04 | 200 | 57 | 4 | 682960e28542a3d6c119047cd0131941932cfdea | |
| ToppCell | LPS_anti-TNF-Mesenchymal_myocytic-Pericyte|LPS_anti-TNF / Treatment groups by lineage, cell group, cell type | 1.24e-04 | 200 | 57 | 4 | 4e1e19214aeebbdca004de7faaf4cc9d18498591 | |
| ToppCell | LPS_IL1RA-Mesenchymal_myocytic-Pericyte-Pericyte_2|LPS_IL1RA / Treatment groups by lineage, cell group, cell type | 1.24e-04 | 200 | 57 | 4 | cf883ba5dbe6350b93142d625a52b25ff2a8bb63 | |
| ToppCell | Parenchymal-NucSeq-Stromal-Fibroblastic-Fibro_alveolar|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 1.24e-04 | 200 | 57 | 4 | 34f52003988ce6329d8deeee1ab875fa77e01e9d | |
| Disease | Weill-Marchesani syndrome (implicated_via_orthology) | 1.02e-05 | 3 | 55 | 2 | DOID:0050475 (implicated_via_orthology) | |
| Disease | Weill-Marchesani syndrome | 2.04e-05 | 4 | 55 | 2 | cv:C0265313 | |
| Disease | Weill-Marchesani syndrome (is_implicated_in) | 2.04e-05 | 4 | 55 | 2 | DOID:0050475 (is_implicated_in) | |
| Disease | hair morphology | 2.16e-05 | 29 | 55 | 3 | EFO_0005038 | |
| Disease | obesity | 8.69e-05 | 241 | 55 | 5 | EFO_0001073 | |
| Disease | lung adenocarcinoma (is_implicated_in) | 1.06e-04 | 49 | 55 | 3 | DOID:3910 (is_implicated_in) | |
| Disease | tooth agenesis (is_implicated_in) | 1.52e-04 | 10 | 55 | 2 | DOID:0050591 (is_implicated_in) | |
| Disease | motor function measurement | 1.86e-04 | 11 | 55 | 2 | EFO_0010749 | |
| Disease | Oligodontia | 2.22e-04 | 12 | 55 | 2 | C4082304 | |
| Disease | gallbladder cancer (is_implicated_in) | 2.63e-04 | 13 | 55 | 2 | DOID:3121 (is_implicated_in) | |
| Disease | central corneal thickness | 2.76e-04 | 309 | 55 | 5 | EFO_0005213 | |
| Disease | Hypodontia | 3.06e-04 | 14 | 55 | 2 | C0020608 | |
| Disease | Malignant lymphoma, lymphocytic, intermediate differentiation, diffuse | 4.03e-04 | 16 | 55 | 2 | C0334634 | |
| Disease | Prostatic Neoplasms | 9.83e-04 | 616 | 55 | 6 | C0033578 | |
| Disease | Malignant neoplasm of prostate | 9.83e-04 | 616 | 55 | 6 | C0376358 | |
| Disease | Mental Retardation, X-Linked | 1.34e-03 | 29 | 55 | 2 | C1136249 | |
| Disease | corneal resistance factor | 1.51e-03 | 451 | 55 | 5 | EFO_0010067 |
| Peptide | Gene | Start | Entry |
|---|---|---|---|
| TVCGPGKICIHKKCV | 611 | Q9UKJ8 | |
| KKRKACKNCTCGLAE | 241 | Q6FI81 | |
| CVHGKCQKIGCDGII | 666 | Q8TE56 | |
| LGCGHTVCKMCLNKL | 31 | Q5TC82 | |
| ALANKCCHVGCTKRS | 166 | P04090 | |
| CRHCGRLLCHKCSTK | 1126 | Q9P2R3 | |
| GCFIKGQNSKCLHCI | 726 | Q8TAB3 | |
| DQKKRGGHKACCLLT | 41 | Q9Y215 | |
| CHKQACLPLRCGKGQ | 251 | Q86XX4 | |
| KCPLNHIACLGTNKC | 76 | Q9NZR2 | |
| TVCCHCGGKTKEAQK | 116 | Q12791 | |
| EKHCRCGKHTKRMPC | 446 | Q6ZNB6 | |
| CRLKCHNKCTKEAPA | 376 | Q8IVT5 | |
| ELCNGKCKSKQLCRS | 496 | Q5TB30 | |
| SCLKICGKDLKCGNH | 556 | Q12986 | |
| FRCANGQCIGKHKKC | 1331 | O75581 | |
| SCKAGQKKCTCHRPG | 176 | Q8IZP7 | |
| LCKSKHTCGHDCCKI | 1146 | A2PYH4 | |
| CVCGKCSCHKIKLGK | 526 | P26012 | |
| KLCKLRKGNCSSTVC | 316 | P01133 | |
| HGKCRNTIGSFKCRC | 1041 | P35555 | |
| GLLKNKHGCDICRCK | 551 | Q9NZV1 | |
| KHGCDICRCKKCPEL | 556 | Q9NZV1 | |
| KKCATGNALCGKLQC | 561 | Q13443 | |
| LKECKAQHIKKQCGC | 316 | Q9NY37 | |
| GLSCEVCKFKAHKRC | 191 | Q16760 | |
| ASNKLPCNCGAKKCR | 3951 | Q03164 | |
| PGCRCKHTNSVICKA | 271 | Q9C004 | |
| KDCGANCHKQCKDLL | 526 | Q8IV61 | |
| ISDKCRKKNICHHCG | 146 | O14802 | |
| GLHKKAILCLCKQGQ | 431 | Q8NHS4 | |
| NTRCEKCQKGVHAKC | 571 | Q6P3X8 | |
| IHVVGNVCQCRKCGK | 246 | Q5HYK9 | |
| GKCGHENLQLKKCCK | 116 | P0CB33 | |
| KIGLRQHHCRKCGKA | 306 | Q96P53 | |
| QHHCRKCGKAVCGKC | 311 | Q96P53 | |
| CRKGIVCNLCGKRGH | 366 | Q9NUD5 | |
| PQGHSCAVCGKVKCK | 96 | Q9Y5W7 | |
| CAVCGKVKCKRHRPS | 101 | Q9Y5W7 | |
| GLRCKACKMSIHHKC | 136 | Q99469 | |
| HGVGKLCKCNDCHKV | 66 | P52743 | |
| CQAIKCKHGKCRLSG | 1416 | O94813 | |
| QNRCVHSQCKKKCGE | 1491 | Q9P2E3 | |
| HSQCKKKCGELCSPC | 1496 | Q9P2E3 | |
| KKTKHCISCNKCVSG | 136 | Q9H8X9 | |
| HTRVNFCKCEKCGKA | 196 | P17038 | |
| SCRKCGKGFAKQCKL | 426 | Q8N393 | |
| ISIGKKCHKCSICGK | 971 | P59923 | |
| KIHTGEKACKCNECG | 361 | Q8NF99 | |
| LKCKCHGLSGSCEVK | 201 | P56704 | |
| SCGGHCKKGKCESHQ | 251 | Q9NV66 | |
| KCKCHGTSGSCQLKT | 261 | Q9GZT5 | |
| KKTKHCISCNKCVSG | 136 | P0C7U3 | |
| LHLCCICGGKKSHIR | 71 | Q59H18 | |
| KCGQAVCGKCSSKRS | 316 | Q8IWB7 | |
| KAARCHACKRQGKLL | 716 | Q14202 | |
| KCGECGKCFSHKGNL | 661 | B7Z6K7 | |
| FCKGNQCRKVCGHKQ | 251 | Q9Y473 | |
| CGKGFRCRSALKVHC | 206 | Q9UK12 | |
| HCQRKPLKCEDCGKR | 391 | Q9UK12 | |
| CARVCHKGHDCKLKR | 1211 | O95071 | |
| GKCGHENLQFKKCCK | 116 | A0A1W2PQL4 |